Atlas Trials

Severe Hypertriglyceridemia

23 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Severe Hypertriglyceridemia

RecordFirmDate
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia (NCT05355402)Ionis Pharmaceuticals, Inc.2022-05-09
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia (NCT05079919)Ionis Pharmaceuticals, Inc.2021-10-25
Safety and Efficacy of MAT9001(Omega-3-pentaenoic Acid) in Subjects With Triglycerides ≥500 mg/dL and <2000 mg/dL (NCT04662528)Matinas Biopharma, Inc2021-06-01
Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia (NCT04720534)Arrowhead Pharmaceuticals2021-05-31
Study to Explore the Efficacy and Safety of BIO89-100 (Pegozafermin) in Participants With Severe Hypertriglyceridemia (NCT04541186)89bio, Inc.2020-09-01
A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia (NCT02944383)NeuroBo Pharmaceuticals Inc.2016-12-01
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function (NCT03001817)Kowa Research Institute, Inc.2016-11-28
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment (NCT03011450)Kowa Research Institute, Inc.2016-11-26
An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis (NCT02189252)AstraZeneca2014-10-01
Epanova® for Lowering Very High Triglycerides (NCT01242527)AstraZeneca2011-01-01
Efficacy Study to Treat Subjects With Severe Hypertriglyceridemia (NCT01229566)Trygg Pharma, Inc.2010-10-01
Epanova® Compared to Lovaza® In a Pharmacokinetic, Single-dose, Evaluation (NCT01208961)AstraZeneca2010-09-01
The Efficacy of EPA+DHA (SC401B) for Lowering Triglyceride Levels (≥ 500 mg/dL) (NCT01997268)Sancilio and Company, Inc.

Track Severe Hypertriglyceridemia automatically

Every clearance here is in the API, with alerts when new ones post.